|
|
Volumn 12, Issue 8, 2001, Pages 1133-1137
|
|
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
a
|
|
Author keywords
Gastric cancer; Paclitaxel; Phase II trial
|
|
Indexed keywords
CIMETIDINE;
CISPLATIN;
DEXAMETHASONE;
DIPHENHYDRAMINE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
METHOTREXATE;
MITOMYCIN C;
PACLITAXEL;
RANITIDINE;
ADJUVANT CHEMOTHERAPY;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
ARTHRALGIA;
ARTICLE;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSS RESISTANCE;
DISEASE SEVERITY;
DRUG HYPERSENSITIVITY;
DRUG INFUSION;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG TOXICITY;
FATIGUE;
FEMALE;
HUMAN;
HYPERTENSION;
HYPOTENSION;
INCIDENCE;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
MYALGIA;
NAUSEA;
NEUROPATHY;
NEUTROPENIA;
PERFORMANCE;
PERIPHERAL NEUROPATHY;
PHASE 3 CLINICAL TRIAL;
PREMEDICATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
SCORING SYSTEM;
SHORT COURSE THERAPY;
STATISTICAL ANALYSIS;
STOMACH CANCER;
TIME;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
DRUG ADMINISTRATION SCHEDULE;
DRUG HYPERSENSITIVITY;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PREMEDICATION;
STOMACH NEOPLASMS;
SURVIVAL ANALYSIS;
|
|
EID: 0034830598
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1011680507956 Document Type: Article |
|
Times cited : (150)
|
|
References (24)
|
